Outlook 2027
The global pharmaceutical market is projected to reach approximately $1.6 trillion to over $2 trillion in 2026, driven by biologics innovation, an aging population, and rising chronic diseases. The industry faces a transformative period, with significant growth in AI-driven drug discovery, a $350 billion patent cliff (2025–2030), and localized manufacturing shifts.
The APAC pharmaceutical market is experiencing robust growth, projected to grow at a CAGR of 7.1% from 2026 to 2033, reaching over US$ 611 billion by 2033. Driven by aging populations, rising healthcare and increasing chronic disease burden, the sector is seeing strong growth in biologics, biosimilars, and generic drug manufacturing, particularly in China and India.
India’s pharmaceutical industry is set to grow at 7–9% in 2027, entering a resilient yet transitional phase. Growth is being driven by strong domestic demand for chronic therapies and sustained export momentum, even as the sector shifts from volume-led generics to value-driven segments such as complex biologics, biosimilars, and specialty products.
Amid patent expiries and pricing pressures, companies are moving toward complex generics and digital-first manufacturing. The industry is evolving from volume leadership to positioning India as an innovation-driven biopharmaceutical hub.
About Pharma Industry Outlook 2027
The first edition of the Indian Pharma Post (IPP) Compendium titled “PHARMA INDUSTRY OUTLOOK (PIO) 2027”, an exclusive collection of premium content curated for policymakers, industry leaders, innovators, and investors, will spotlight a phase of resilient growth, innovation-led expansion, and increasing global integration, driven by digital transformation, evolving regulatory framework, and a strong push towards self-reliance and advanced therapeutics.
Built on deep editorial expertise and industry engagement, PIO 2027 will present a comprehensive, insight-driven analysis of India’s pharmaceutical sector, capturing its transformation into a global healthcare powerhouse.
The Compendium aims to provide an in-depth analysis of pharmaceuticals, healthcare, biotechnology, and allied sectors by featuring industry leaders’ perspectives, interviews from leaders in the government, industry, academia, associations, and R&D organizations amongst others. It also focuses on Digitalization & Automation, Technology, Lab, Sustainability, and Supply Chain & Logistics etc.
IPP Pharma Industry Outlook 2027 will be released in November 2026 and copies of the same will be distributed to key industry stakeholders through both offline and online channels. The Compendium will also be available in digital format on Indian Pharma Post News website (www.indianpharmapost.com).
Compendium Structure
- Foreword
- Executive Summary
- Indian Pharma Industry
- Market & Economic Outlook
- Policy & Regulatory Landscape
- Technology & Innovation Trends
Distribution
- Print Edition 6,000+ Print Copies
- E-Version 35,000+ Digital Circulation
- Digital: 95,000 Microsite Views
Target Audience
- Policymakers & regulators
- Pharma, biotech & medtech leaders
- Academia & research institutions
- CDMOs & CROs
- Technology and Equipment Suppliers
- Startups & innovators
- Investors & financial institutions
Focus Sectors
- Active Pharmaceutical Ingredients
- Formulations
- Specialty and Complex Generics
- Biopharmaceuticals
- CRAMS / CDMO / CRO
- Medical Devices and Diagnostics
- Digital Health and Pharma IT
- Nutraceuticals and Wellness
- Distribution and Supply Chain
- Regulatory and Compliance Ecosystem
- Sustainability and ESG
Past Editions
Key Industry Segments
- Chemicals
- Petrochemicals
- Digitalization
- Supply Chain
- Battery, Semicon & Advanced Materials
- Bioenergy
- Fertilizer
- Sustainability
- Home & Personal Care
- Flavours & Fragrances
- EPC
Partners
Article submission form
Highlights - IPP PHARMA INDUSTRY OUTLOOK 2027
Verticals Covered - Chemicals, Petrochemicals, BioFuels, EV & Battery Chemicals, and Hydrogen
New Verticals Added - Fertilizers, Paints & Coatings, Dye & Dyestuffs, Adhesives & Sealants, and High Performance Polymers
International Perspective - Incorporated in all segments
Segments Covered - Digitalization & Automation, Sustainability, and Supply Chain & Logistics
Complete 360 Degree - Views from Policy Makers, Analysts, Industry, Academia, and R&D Institutions
General Guidelines:
IPP shall only publish those articles which reaches as per the given timelines against your indicated area of interest.
Content is invited for publishing on Compendium & E-version
IPP shall not charge any fees towards publishing article in the compendium. However you may have to purchase print version of the compendium since it’s a paid version and copyright of IPP.
Every article shall carry a disclaimer at the end of the section stating “All views expressed in the article are those of the author and IPP does not have influence over any cause or damage related to it.
Word count should be 800-1200 words
Author’s short bio, photo, contact details
Article needs to be submitted via online mode ONLY. No other modes of communications shall be entertained.
No mention of the company or its products & services in the article
Indian Pharma Post is an online platform that provides news and insights on the pharmaceutical industry. It reports on the latest news updates, drug discoveries, and research reports. It highlights trending topics in the entire healthcare universe and will lay emphasis on the new best practices across the spectrum of the industry. It hosts a team of experts who will provide insights on policies that shape developments in the industry.
_256_384.jpeg)
